Circulating GPC4 has been previously associated with several disorders linked to insulin resistance including elevated systolic blood pressure (27), non-alcoholic fatty liver disease (26), and kidney disease (30, 44). Here, GPC4 is linked to metabolic dysfunction-associated steatotic liver disease.